Clinical and experimental studies on DCM have consistently shown that mTOR overactivation is a major contributor to the development of DCM, providing new insights into the complex regulatory mechanisms of the mTOR signaling pathway [84]. This evidence concerns the gene MTOR and familial dilated cardiomyopathy.